AIM
ANIK icon

Assured Investment Management’s Anika Therapeutics ANIK Stock Holding History

Assured Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-708
Closed -$21K – 89
2019
Q1 		$21K Sell
708
-12,181
-95% -$417K ﹤0.01% 1020
2018
Q4 		$433K Buy
12,889
+708
+6% +$25.6K 0.01% 702
2018
Q3 		$514K Buy
12,181
+2,332
+24% +$92.1K 0.01% 756
2018
Q2 		$315K Sell
9,849
-3,799
-28% -$156K 0.01% 931
2018
Q1 		$679K Buy
+13,648
New +$771K 0.02% 675

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assured Investment Management's ANIK Position: Q2 2019 in Review

Assured Investment Management sold out of Anika Therapeutics (ANIK) in Q2 2019, closing a stake of 708 shares — an estimated $21K sold.

Assured Investment Management first reported a position in ANIK in Q1 2018 and held it in 5 quarters. The position peaked at $679K in Q1 2018. 165 funds tracked by Wall St. Rank hold ANIK as of Q2 2019.

  • Assured Investment Management reported no remaining Anika Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 708 Anika Therapeutics shares in Q2 2019, an estimated $21K.
  • Assured Investment Management first reported a position in Anika Therapeutics in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Anika Therapeutics position peaked at $679K in Q1 2018.
  • 165 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.